Last updated on March 2018

Patients are needed to participate in a clinical research study to evaluate Human Papillomavirus Infection, Condyloma acuminatum, Malignant neoplasm of vulva, Vaginal Cancer, Cervical Cancer


Brief description of study

This study will assess the safety and immunogenicity of GARDASIL9 (V503) in 27- to 45-year-old women, and will complete the evaluation of GARDASIL9 in the extended age range of female participants for whom GARDASIL was proven to be effective. The primary hypothesis of the study states that anti-HPV 16, 18, 31, 33, 45, 52, and 58 titers at 4 weeks postdose 3 are non-inferior in adult women as compared with titers in young adult women.

Clinical Study Identifier: NCT03158220

Contact Investigators or Research Sites near you

Start Over

Universitatsklinik fuer Frauenheilkunde und Geburtshilfe ( Site 0002)
Graz, Austria

Klin. Abtlg. fuer Gynaekologie und Geburtshilfe ( Site 0001)
Wien, Austria

HUS Katiloopiston sairaala ( Site 0009)
Helsinki, Finland

Ita-Helsingin Rokotetutkimuskeskus ( Site 0011)
Helsinki, Finland

Porin Rokotetutkimusklinikka ( Site 0012)
Pori, Finland

Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0010)
Tampere, Finland

Turun rokotetutkimusklinikka ( Site 0037)
Turku, Finland

Universitaetsmedizin Berlin Charite ( Site 0016)
Berlin, Germany

Universitaetsklinikum Duesseldorf ( Site 0014)
Dusseldorf, Germany

Praxis Dr. Peters ( Site 0015)
Hamburg, Germany

Universitaetsklinikum Hamburg-Eppendorf ( Site 0017)
Hamburg, Germany

Universitaetsklinikum Tuebingen ( Site 0013)
Tuebingen, Germany

Istituto Nazionale dei tumori ( Site 0020)
Milano, Italy

Ospedale San Raffaele ( Site 0022)
Milano, Italy

Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello ( Site 0023)
Palermo, Italy

CAP Centelles ( Site 0027)
Centelles, Spain

Institut Catala Oncologia de Bellvitge - ICO ( Site 0026)
Hospitalet de Llobregat, Spain

Hospital Sanitas La Moraleja ( Site 0031)
Madrid, Spain

Hospital Universitario Infanta Leonor ( Site 0028)
Madrid, Spain

Universitair Ziekenhuis Antwerpen ( Site 0007)
Edegem, Belgium

Universitair Ziekenhuis Gent ( Site 0006)
Gent, Belgium

Universitair Ziekenhuis Gasthuisberg ( Site 0005)
Leuven, Belgium

University of Antwerp ( Site 0004)
Wilrijk, Belgium

Complejo Hospitalario de Torrecardenas ( Site 0030)
Almeria, Spain